Last reviewed · How we verify

NCT04229589: SYNCOPACED

Risk of Syncopal Relapses in Patients Treated With Permanent Pacing for Bradyarrhythmic Syncope

Status unknown Last updated 18 January 2020
What this trial tests

trial testing Clinic follow-up in Syncope in 1,364 participants. Status unknown.

Timeline
1 January 2010
Primary endpoint
1 March 2020
1 May 2020

Quick facts

Lead sponsorAzienda Ospedaliera Cardinale G. Panico
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,364
Start date1 January 2010
Primary completion1 March 2020
Estimated completion1 May 2020
Sites7 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliera Cardinale G. Panico

Who can join

18 and older, any sex, with Syncope. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, multicenter, observational registry designed to collect data on syncopal relapses in patients undergoing pacemaker implantation for bradyarrhythmic syncope.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Syncope

Currently open trials in the same condition.

Other Azienda Ospedaliera Cardinale G. Panico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04229589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing